Unlike the idiopathic form, inflammation and autoimmunity are believed to contribute to the initiation and progression of CTD-PAH via endothelin 1, nitric oxide, and prostacyclin pathways.6 Here, EDN1 is linked to pulmonary arterial hypertension.